The Secretary for Health emphasised that the expansion of the "1+" mechanism will not affect the quality of medicine. Starting next month, the mechanism will cover all new drugs, including vaccines and advanced therapy products. Currently, it only includes new drugs for treating life-threatening or severely debilitating diseases. Speaking on a Commercial Radio programme on Saturday, Lo Chung-mau pointed out that the relaxation only changes the mode of approval, not the requirements for approval. He believes the move will elevate the region's healthcare standard - the reason being that Hong Kong-registered drugs can be used in designated health institutions on the mainland, even if they have not been registered there. "We will be able to, one, allow patients in Hong Kong and even in the Greater Bay Area to enjoy more advanced therapy products or new drugs...with the improvement of healthcare standard in the whole area." "Two, with more choices, the cost of these new treatment drugs or advanced therapy products will be lowered. Thirdly, it will promote the development of R&D - research and development - in the area." Lo pointed out that the move will be attractive for pharmaceutical companies, as they can enjoy access to a bigger market. "Once the drug or device gets approved and registered in Hong Kong and is in-use at public hospitals, it will have a 'green channel' for use in the 86 million population of the GBA." Meanwhile, Chief Executive John Lee voiced his support towards building a third medical school by local universities, in his third policy blueprint. The health chief said it's "definitely good" to have one more medical institute, but warned that if the third medical institute is not up to scratch, it may affect the quality of the current two schools. "We have to be cautious, because a medical school involves a lot of resources, not just capital, for medical training, such as professors...a teaching hospital, and even patients. Because teaching is not only held in classrooms, we need medical cases to do so."
